Bitte wählen Sie:

Universitätsklinikum Essen

Univ.-Prof. Dr. phil. nat. Katharina Lückerath

Professor Preclinical Theranostics

Katharina is a biomedical scientist with a focus on experimental and translational theranostics. She is interested in understanding mechanisms underlying failure of radioligand therapy, and aims at improving theranostic approaches and thus, outcomes for cancer patients. Katharina obtained her PhD at the Institute for Tumor Biology and Experimental Therapy (Georg-Speyer-Haus, Germany). She served as head of the research group Experimental Oncology in Nuclear Medicine at the University of Würzburg (Germany), and of the pre-clinical Nuclear Medicine team at the University of California Los Angeles (USA), before transferring to University Hospital Essen in March 2021.


Magdalena Staniszewska

Graduate Student

Magdalena focused on thyroid cancer during her undergraduate career and obtained her M.Sc. from the Institute of Pathology, University Duisburg- Essen. In 2018, she joined our group as a doctoral researcher. She is a member of GRK 1739 training program which aims on understanding what determines the cellular response to ionizing radiation with the goal of providing a scientific basis for effective response modulation. In her PhD project she focuses on establishing radioligand and drug combination therapies for advanced prostate cancer.


Jasmin Wosniack

State-certified biological-technical assistant

Jasmin completed her training as a biological technical assistant in Düsseldorf in 2017. Since 2018 she works in our preclinical research group. Currently she focuses on preclinical imaging and translational oncology. In addition, she coordinates and performs PET/CT imaging for cooperation projects with internal and external research groups.




Experimental Radiochemistry

Dr. Valeska von Kiedrowski


Valeska obtained her PhD from the University of Dortmund for the total synthesis and structural elucidation of complex natural products in the field of organic chemistry. During her PostDocs her research focus was expanded by the design, bioconjugation, radiolabelling and in vitro/in vivo evaluation of new radiotracers. She joined our team in 2021 and is currently working on automating the radiolabeling of liposomes. Valeska enjoys to learn from future collaborative projects.


Dr. Anna Pacelli


Anna is a medicinal chemist/radiochemist with postdoctoral experience in organic synthesis, fluorine-18 and carbon-11 radiolabelling, and automation. Her research focuses on the development of novel PET tracers and the optimisation of radiosynthesis and quality control for clinical applications.